Drug firm fined for huge price rise that hit NHS – BBC News

Posted July 29th, 2021 in competition, consumer protection, fines, medicines, news by sally

‘A drug company that increased the price of a crucial thyroid remedy more than 10-fold has prompted fines of more than £100m by the competition watchdog.’

Full Story

BBC News, 29th July 2021

Source: www.bbc.co.uk

Research Briefing: General debate: Misuse of Drugs Act – House of Commons Library

Posted June 17th, 2021 in drug abuse, drug offences, medicines, news, parliament, statistics by sally

‘This year marks the fiftieth anniversary of the Misuse of Drugs Act 1971, the main piece of legislation through which illicit drugs are controlled across the UK.’

Full Story

House of Commons Library, 16th June 2021

Source: commonslibrary.parliament.uk

A new ABPI Code for 2021 – Mills & Reeve

Posted June 8th, 2021 in agreements, codes of practice, medicines, news by sally

‘The 2021 version of the ABPI Code will come into effect on 1 July. This brings in important changes to the self-regulatory system for the UK pharma industry. It amounts to the most substantial refresh of the Code since the 1990s.’

Full Story

Mills & Reeve, 4th June 2021

Source: www.mills-reeve.com

Parents can consent to children being given puberty blockers, High Court rules – The Independent

‘Parents can consent to their child being given puberty blockers without applying for a court’s approval, the High Court has ruled following a case that contested whether under-16s were able to give permission themselves.’

Full Story

The Independent, 27th March 2021

Source: www.independent.co.uk

The UK’s new medicines and medical devices regime – next steps – Mills & Reeve

Posted March 12th, 2021 in chambers articles, enforcement, medicines, news by sally

‘The Medicines and Medical Devices Act has now become law. Much of the legislation simply sets up powers and frameworks for development of the UK’s regulatory system for medicines, veterinary medicines and medical devices. Importantly, Part 4 of the Act introduces a new enforcement regime for medical devices, replacing provisions currently scattered across other legislation.’

Full Story

Mills & Reeve, 5th March 2021

Source: www.mills-reeve.com

Doctors acted unlawfully in deciding on eligibility for drug – Court of Appeal – UK Human Rights Blog

Posted March 4th, 2021 in children, evidence, judicial review, medical treatment, medicines, news by sally

‘Sophie Basma (“Sophie”) is 10. She suffers from Type 3 Spinal Muscular Atrophy (“SMA”). SMA is a rare, genetic, neuromuscular disease which progressively leads to sufferers being unable to walk or sit unaided with devastating consequences on their quality of life. Sophie can no longer walk. There is medication for SMA sufferers which would have had the potential of helping Sophie regain her ability to work. But the NHS Trust had concluded that Sophie did not meet the eligibility criteria for this new medication, “Nusinersen”.’

Full Story

UK Human Rights Blog, 4th March 2021

Source: ukhumanrightsblog.com

Sutton Coldfield pharmacist jailed over £1m black market pills sale – BBC News

‘A pharmacist who illegally sold addictive prescription pills valued at more than £1m on the black market has been jailed for 12 months.’

Full Story

BBC News, 2nd March 2021

Source: www.bbc.co.uk

Police boss wants to trial giving cannabis to prisoners – The Independent

Posted March 1st, 2021 in drug abuse, drug offences, medicines, news, police, prisons, statistics by tracey

‘Prisoners should be given cannabis to help deal with addiction problems and tackle violence, according to a police and crime commissioner (PCC) in Wales.’

Full Story

The Independent, 28th February 2021

Source: www.independent.co.uk

New Acts – legislation.gov.uk

Posted February 12th, 2021 in legislation, medical treatment, medicines, pensions, railways by tracey

Pension Schemes Act 2021

High Speed Rail (West Midlands – Crewe) Act 2021

Medicines and Medical Devices Act 2021

Source: www.legislation.gov.uk

Astra-Zeneca v EU – the vaccine row explained in straightforward terms – The 36 Group

Posted February 11th, 2021 in chambers articles, contracts, coronavirus, EC law, medicines, news by sally

‘On 1 February, AstraZeneca told the EU that it would deliver around 50% of the 80 million COVID-19 vaccine doses that it had previously told the EU for the first quarter of 2021.’

Full Story

The 36 Group, 10th February 2021

Source: 36group.co.uk

Gosport hospital deaths: Families ‘need Hillsborough-style inquests’ – BBC News

‘Relatives of patients who died after receiving “dangerous” levels of painkillers at Gosport War Memorial Hospital have called for new inquests.’

Full Story

BBC News, 5th February 2021

Source: www.bbc.co.uk

Puberty Blocking — can a child consent? – UK Human Rights Blog

‘A case about medical treatment for children experiencing gender dysphoria is bound to evoke strong feelings. So, in early October, when the parties in R (on the application of Quincy Bell and A v Tavistock and Portman NHS Trust and others arrived for the hearing at the Royal Courts of Justice, they found a buzz of press photographers and a throng of campaigners with placards.’

Full Story

UK Human Rights Blog, 4th December 2020

Source: ukhumanrightsblog.com

Puberty blockers: under-16s ‘unlikely to be able to give informed consent’ – The Guardian

‘Children under the age of 16 considering gender reassignment are unlikely to be mature enough to give informed consent to be prescribed puberty-blocking drugs, the high court has ruled.’

Full Story

The Guardian, 1st December 2020

Source: www.theguardian.com

EP 128: The Cumberlege Review – Marina Wheeler QC – Law Pod UK

Posted October 26th, 2020 in doctors, health, hospitals, medical treatment, medicines, news, podcasts by sally

‘In Episode 128 Emma-Louise Fenelon talks to Marina Wheeler QC about the Cumberlege Review, which investigated the response of England’s healthcare system to patients’ reports of harm from drugs and medical devices.’

Full Story

Law Pod UK, 22nd October 2020

Source: audioboom.com

Teenager’s death after being given antipsychotic was ‘potentially avoidable’ – The Guardian

‘The death of a teenager who was given antipsychotic medication though he and his family warned that the drug might cause him serious harm could have been avoided, an independent review has concluded.’

Full Story

The Guardian, 20th October 2020

Source: www.theguardian.com

Parents of toddler with severe epilepsy seek legal review of cannabis oil guidelines – The Guardian

Posted August 17th, 2020 in children, health, judicial review, medicines, news by sally

‘The parents of a toddler with severe epilepsy are seeking a landmark judicial review of rigid guidelines that effectively prevent the NHS from prescribing medical cannabis oil, a substance that they say has allowed their son to live a much healthier life, to thousands of sick children.’

Full Story

The Guardian, 16th August 2020

Source: www.theguardian.com

Case Comment – General Pharmaceutical Council v Kellett & Gamble (2020) QBD (Admin) 01/07/20; 6 WLUK 456: Regulator’s application to extend interim suspension orders: – Park Square Barristers

‘This was an application by the GPhC to extend interim orders for the suspension of the respondent husband and wife pharmacists who were co-directors of a company which owned three pharmacies.’

Full Story

Park Square Barristers, 6th July 2020

Source: www.parksquarebarristers.co.uk

New Judgment: Regeneron Pharmaceuticals Inc v Kymab Ltd [2020] UKSC 27 – UKSC Blog

Posted June 25th, 2020 in inventions, medicines, news, patents, Supreme Court by sally

‘Regeneron Pharmaceuticals Inc filed patents for a new type of genetically modified mouse which was a hybrid version of the gene that produces antibodies, combining a section of the mouse’s genetic material with a section of the genetic material from a human. In 2013, Regeneron sued Kymab Ltd for infringements of its patents. Kymab was producing its own genetically modified mice, with a similar genetic structure to Regeneron’s mice. Kymab argued that the patents filed were invalid because they fell foul of a patent law rule called sufficiency which means that documents filed with the patent must be detailed enough to enable scientifically skilled readers to make the invention for themselves. The Court of Appeal upheld the patents and Kymab appealed to the Supreme Court.’

Full Story

UKSC Blog, 24th June 2020

Source: ukscblog.com

Navigating Market Authorisation in the UK for the pharmaceutical industry – 3PB

Posted June 18th, 2020 in health, licensing, medicines, news by sally

‘‘Marketing Authorisation’ must be obtained in respect of any medicinal product that is to be sold, supplied or offered for sale or supply in the UK. This article looks at the different types of authorisation available, including when they might be appropriate for use in respect of the UK only before considering the process adopted in the UK for approving medicines into the market. It is designed to be a beginner’s guide to bringing new products to market in the UK as opposed to a full explanation of each step; ultimately how the application itself is make will depend on the product itself and the research behind it. If upon reading this article you gain an understanding of how to begin the Market Authorisation process, then this article has served its purpose.’

Full Story

3PB, 4th June 2020

Source: www.3pb.co.uk

Patents – Neurim Pharmaceuticals v Mylan – NIPC Law

Posted June 5th, 2020 in appeals, damages, injunctions, intellectual property, medicines, news, patents by sally

‘This was an application by Neurim Pharmaceuticals (1991) Ltd. (“Neurim”), the registered proprietor of European patent (UK) number 1441702 and Flynn Pharma Ltd. (“Flynn”) the proprietor’s exclusive licensee for an interim injunction to restrain until trial or further order the generics manufacturer, Mylan, from taking steps that might infringe that patent. The application was heard online by Mr Justice Marcus Smith on 20 May 2020. He handed down his judgment on 3 June 2020.’

Full Story

NIPC Law, 4th June 2020

Source: nipclaw.blogspot.com